{"organizations": [], "uuid": "9379319b36db17df9bab3126d1dd84c404c99608", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "in.reuters.com", "main_image": "https://s1.reutersmedia.net/resources/r/?m=02&d=20180329&t=2&i=1245892282&w=1200&r=LYNXMPEE2S012", "site_section": "http://feeds.reuters.com/reuters/INbusinessNews\r", "section_title": "Reuters: Money News", "url": "https://in.reuters.com/article/shire-m-a-takeda-pharma/drugmaker-takeda-shares-tumble-as-company-considers-bid-for-shire-idINKBN1H502X", "country": "US", "domain_rank": 408, "title": "Drugmaker Takeda shares tumble as company considers bid for Shire", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-29T03:34:00.000+03:00", "replies_count": 0, "uuid": "9379319b36db17df9bab3126d1dd84c404c99608"}, "author": "", "url": "https://in.reuters.com/article/shire-m-a-takeda-pharma/drugmaker-takeda-shares-tumble-as-company-considers-bid-for-shire-idINKBN1H502X", "ord_in_thread": 0, "title": "Drugmaker Takeda shares tumble as company considers bid for Shire", "locations": [], "entities": {"persons": [{"name": "takeda pharmaceutical", "sentiment": "none"}, {"name": "minami funakoshi", "sentiment": "none"}, {"name": "takeda", "sentiment": "none"}, {"name": "shire", "sentiment": "none"}, {"name": "chang-ran kim", "sentiment": "none"}], "locations": [{"name": "tokyo", "sentiment": "none"}, {"name": "tokyo", "sentiment": "none"}, {"name": "japan", "sentiment": "none"}], "organizations": [{"name": "drugmaker takeda", "sentiment": "negative"}, {"name": "takeda", "sentiment": "negative"}, {"name": "takeda pharmaceutical", "sentiment": "none"}, {"name": "shire", "sentiment": "none"}, {"name": "shire reuters", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 29, 2018 / 12:38 AM / Updated 23 minutes ago Drugmaker Takeda shares tumble as company considers bid for Shire Reuters Staff 1 Min Read \nTOKYO (Reuters) - Takeda Pharmaceutical ( 4502.T ) shares sank 5 percent early on Thursday, a day after Japan’s largest drugmaker said it was considering a bid for London-listed rare disease specialist Shire ( SHP.L ) that could top $40 billion. FILE PHOTO: Takeda Pharmaceutical's signboard is seen on its headquarters building in Tokyo, Japan January 30, 2018. Picture taken January 30, 2018. REUTERS/Kim Kyung-Hoon/File Photo \nShares in Takeda fell more than 5 percent in early morning trade, sharply underperforming the broader Tokyo market .TOPX , which was slightly higher. \nTakeda said on Wednesday it was “at a preliminary and exploratory stage” of considering a bid that could spark another takeover battle in the deal-hungry pharma industry. Shire’s shares ended 15.7 percent higher, valuing the group at around 32 billion pounds ($45 billion). Reporting by Minami Funakoshi; Editing by Chang-Ran Kim", "external_links": [], "published": "2018-03-29T03:34:00.000+03:00", "crawled": "2018-03-29T04:16:41.000+03:00", "highlightTitle": ""}